
Keywords: Apo; apolipoprotein; BPsys; systolic blood pressure; CS; chondroitin sulfate; CVD; cardiovascular disease; DS; dermatan sulfate; EDTA; ethylene diamine tetraacetic acid; GAG; glycosaminoglycan; HS; heparan sulfate; HSBGF; heparan sulfate-binding growth fa